| Earle C Schreiber Inc | |
| 1 Bethany Rd, Ste 13, Hazlet, New Jersey 07730 | |
| (732) 335-1424 |
| Name | Earle C Schreiber Inc |
|---|---|
| Organization Name | Earle C. Schreiber, Inc. |
| Location | 1 Bethany Rd, Ste 13, Hazlet, New Jersey 07730 |
| Type | Supplier |
| Phone | (732) 335-1424 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Scientists investigating how certain genes affect an individual's risk of developing coronary heart disease have identified a new therapeutic target, according to research published today in The American Journal of Human Genetics.
Biologists at the University of Pennsylvania have revealed a hidden code that determines the expression level of a gene, providing a way to distinguish efficient genes from inefficient ones.
For those living with gastrointestinal disorders, such as ulcers or Crohn's disease, treatment often means quelling uncomfortable symptoms through medications or dietary changes. But what if one day treatment meant doing away with the old gut for a new gut free of inflamed or diseased tissues?
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the conclusion of the first Phase II trial testing its unique new hemostat Fibrocaps(TM). Promising preliminary data from the European multicenter, open-label trial show compelling safety and efficacy (time to hemostasis) profiles for Fibrocaps, and good performance of the delivery device.
Biologists at The Johns Hopkins University have discovered that low oxygen conditions, which often persist inside tumors, are sufficient to initiate a molecular chain of events that transforms breast cancer cells from being rigid and stationery to mobile and invasive.
› Verified 8 days ago
News Archive
Scientists investigating how certain genes affect an individual's risk of developing coronary heart disease have identified a new therapeutic target, according to research published today in The American Journal of Human Genetics.
Biologists at the University of Pennsylvania have revealed a hidden code that determines the expression level of a gene, providing a way to distinguish efficient genes from inefficient ones.
For those living with gastrointestinal disorders, such as ulcers or Crohn's disease, treatment often means quelling uncomfortable symptoms through medications or dietary changes. But what if one day treatment meant doing away with the old gut for a new gut free of inflamed or diseased tissues?
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the conclusion of the first Phase II trial testing its unique new hemostat Fibrocaps(TM). Promising preliminary data from the European multicenter, open-label trial show compelling safety and efficacy (time to hemostasis) profiles for Fibrocaps, and good performance of the delivery device.
Biologists at The Johns Hopkins University have discovered that low oxygen conditions, which often persist inside tumors, are sufficient to initiate a molecular chain of events that transforms breast cancer cells from being rigid and stationery to mobile and invasive.
› Verified 8 days ago
All In Medical Corp Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1340 State Route 36, Hazlet, New Jersey 07730 Phone: (732) 847-3044 | |
Earle C Schreiber Inc Type: Medicare Supplier Location: 1 Bethany Rd, Hazlet, New Jersey 07730 Phone: (732) 335-1424 | |
Hazlet Pharmacy Inc Type: Community/Retail Pharmacy Location: 2874 Highway 35, Hazlet, New Jersey 07730 Phone: (732) 264-3310 | |
Cvs Pharmacy #07069 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3391 Highway 35, Hazlet, New Jersey 07730 Phone: (732) 888-8299 | |
Nouveau Prosthetics & Orthotics Type: Prosthetic/Orthotic Supplier Location: 984 Highway 36, Hazlet, New Jersey 07730 Phone: (732) 739-0888 |